Aubrey Capital Management LTD Abiomed Inc Transaction History

Aubrey Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$255.22 - $317.0 $5.61 Million - $6.97 Million	-22,000 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$141.4 - $257.09 $3.11 Million - $5.66 Million	22,000 New	22,000 $5.31 Million
Q2 2019 Aug 22, 2019	SELL	$250.96 - $284.94 $3.16 Million - $3.58 Million	-12,580 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$281.08 - $444.25 $168,648 - $266,550	-600 Reduced 4.55%	12,580 $4.09 Billion
Q3 2018 Nov 08, 2018	SELL	$354.53 - $449.75 $1.36 Million - $1.73 Million	-3,850 Reduced 22.61%	13,180 $0
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $992,709 - $1.59 Million	-3,570 Reduced 17.33%	17,030 $0
Q4 2017 Feb 12, 2018	BUY	$168.78 - $199.74 $3.48 Million - $4.11 Million	20,600	20,600 $0

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Aubrey Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Aubrey Capital Management LTD with notifications on news.